The Cigna Group (CI)
NYSE: CI · Real-Time Price · USD
302.76
-3.11 (-1.02%)
At close: Sep 12, 2025, 4:00 PM EDT
302.80
+0.04 (0.01%)
After-hours: Sep 12, 2025, 7:56 PM EDT
The Cigna Group Revenue
The Cigna Group had revenue of $67.18B in the quarter ending June 30, 2025, with 11.00% growth. This brings the company's revenue in the last twelve months to $262.02B, up 20.23% year-over-year. In the year 2024, The Cigna Group had annual revenue of $247.12B with 26.56% growth.
Revenue (ttm)
$262.02B
Revenue Growth
+20.23%
P/S Ratio
0.32
Revenue / Employee
$3,564,939
Employees
73,500
Market Cap
80.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 247.12B | 51.86B | 26.56% |
Dec 31, 2023 | 195.27B | 14.75B | 8.17% |
Dec 31, 2022 | 180.52B | 6.45B | 3.70% |
Dec 31, 2021 | 174.07B | 13.67B | 8.52% |
Dec 31, 2020 | 160.40B | 6.84B | 4.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CI News
- 3 days ago - Rate of employers covering weight-loss drugs is flat, Cigna says - Reuters
- 3 days ago - The Cigna Group Announces Appearance at the Morgan Stanley 23rd Annual Global Healthcare Conference - PRNewsWire
- 7 days ago - 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025) - Seeking Alpha
- 9 days ago - AM Best Assigns Issue Credit Ratings and Indicative Issue Credit Ratings to The Cigna Group - Business Wire
- 11 days ago - Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers - Benzinga
- 11 days ago - Cigna's Evernorth invests $3.5 billion in Shields - Reuters
- 11 days ago - Evernorth Health Services Announces Investment in Shields Health Solutions - PRNewsWire
- 4 weeks ago - Cigna: Market Pessimism Creates Value Opportunity - Seeking Alpha